Recombinant human Enolase 1/ENO1 protein , 1-434aa

Recombinant human Enolase 1/ENO1 protein , 1-434aa

Catalog Number:
P001445743NKM
Mfr. No.:
ATGP0404
Price:
$240
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

      • Properties
        • Protein Name
          2 phospho D glycerate hydro lyase, Alpha enolase, C myc promoter binding protein, EC 4.2.1.11, ENO1, ENO1L1, Enolase 1 (alpha), Enolase 1 (alpha) like 1, MBP1, MBPB1, MPB1, MYC promoter-binding protein 1, NNE, Non-Neuronal Enolase, Phosphopyruvate hydratase, Plasminogen binding protein, PPH, Tau-crystallin
          Type
          Recombinant Proteins
          Purification
          > 95% by SDS-PAGE
          Formulation
          Liquid. In 20mM Tris-HCl buffer (pH 7.5) containing 1mM MgSO4, 10% glycerol
          Storage
          Stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
          Concentration
          1mg/ml (determined by Bradford assay)
          Molecular Weight
          47.1 kDa (434aa) confirmed by MALDI-TOF
          Expression system
          E.coli

          More Information

          UniProt
          P06733

          * For research use only. Not intended for human, diagnostics or veterinary use.

      • Applications
        • Application
          SDS-PAGE; Enzyme Activity
      • Reference
        • Chen X, et al. Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells. (Oncotarget. 2017)
          Hashimoto Y, et al. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. (Graefes Arch Clin Exp Ophthalmol. 2019)
          Hirakata T, et al. Acute unilateral inner retinal dysfunction with photophobia: importance of electrodiagnosis. (Jpn J Ophthalmol. 2020)
          Hashimoto Y, et al. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status. (Graefes Arch Clin Exp Ophthalmol. 2021)
          Inoue Y, et al. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation. (Cell Mol Life Sci. 2022)

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.